Poland· PL-100432216
Procto-Glyvenol
A local anesthetics product containing tribenosidum + lidocaini hydrochloridum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Tribenosidum + lidocaini hydrochloridum is registered in 2 of 19 countries.
Countries holding a registration under ATC C05AD (local anesthetics), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Tribenosidum + lidocaini hydrochloridum · ATC C05AD
2 / 19 countries
- Polandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Tribenosidum + Lidocaini hydrochloridum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C05AD
- ATC class
- Local anesthetics
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991425210
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tribenosidum + lidocaini hydrochloridum in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaPROCTO-GLYVENOLHerbacos Recordati s.r.o., Pardubice
- SwitzerlandProcto-Glyvenol, RektalcremeHaleon Schweiz AG
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Прокто-Гливенол
- Cyprus · Procto-Glyvenol
- Czechia · Procto-Glyvenol
- Greece · Procto – Glyvenol
- Lithuania · Procto-Glyvenol
- Latvia · Procto-Glyvenol
- Malta · Procto-Glyvenol
- Portugal · Procto-Glyvenol
- Romania · Procto-Glyvenol
- Slovakia · Procto-Glyvenol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/17cd6b3d-e858-404d-bf1f-d1dae0f1fa3d GET /v1/drugs/17cd6b3d-e858-404d-bf1f-d1dae0f1fa3d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krem doodbytniczy",
"source": "urpl",
"strength": "50 mg/g + 20 mg/g",
"packaging": "05909991425210 ¦ OTC ¦ 135567\n1 tuba 30 g",
"substance": "Tribenosidum 50 mg/g + Lidocaini hydrochloridum 20 mg/g",
"common_name": "Tribenosidum + Lidocaini hydrochloridum",
"pl_product_id": "100432216",
"pozwolenie_nr": "75/20",
"auth_procedure": "IR",
"authorisation_validity": "2030-03-13"
}See everything about tribenosidum + lidocaini hydrochloridum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.